On Wednesday, in the course of current trade, Shares of Sprint Corporation (NYSE:S), gained 0.21%, and is now trading at $4.67.
Due to another powerful earthquake, Sprint Corporation is waiving and crediting calls and text messages made by Sprint customers to Nepal – retroactive from April 25, now ongoing through June 1, 2015. Sprint originally declared it would waive customer fees through May 16, 2015 but has extended the timeline to ensure critical contact with family, friends and emergency personnel can be maintained. During times of emergency, it has been shown that text messages may go through when calling capabilities aren’t accessible and may assist free up networks for critical communication between first responders, other emergency personnel and aid workers. Calling and texting to Nepal without charges applies to all postpaid and prepaid customers of Sprint, Boost Mobile and Virgin Mobile USA.
Sprint Corporation provides wireless and wireline communications services to consumers, businesses, and government users in the United States, Puerto Rico, and the U.S. Virgin Islands. It operates in two segments, Wireless and Wireline. The Wireless segment offers wireless data communication services, counting mobile productivity applications, such as Internet access, messaging, and email services; wireless photo and video offerings; location-based capabilities comprising asset and fleet administration, dispatch services, and navigation tools; mobile entertainment applications; and local and long distance wireless voice services, in addition to voicemail, call waiting, three-way calling, caller identification, directory assistance, and call forwarding services.
During an Afternoon trade, Shares of Calpine Corp. (NYSE:CPN), dipped -1.59%, and is now trading at $20.72.
Calpine Corporation, has named W.G. “Trey” Griggs III its Executive Vice President and Chief Commercial Officer effective June 1, 2015. Formerly Mr. Griggs was a Managing Director at Goldman Sachs & Co. At Calpine, Mr. Griggs will have responsibility for the trading, origination, development and commercial analytics groups and will report to Calpine’s Chief Executive Officer.
For the past four years, Mr. Griggs led Goldman Sachs’ North American Energy Risk Administration activities and the Houston Trading Office. Preceding to that, he served in various roles with the Goldman Sachs commodities group in New York. From 1995-2000, he was an attorney at law firms in Houston and Greenville, S.C. Mr. Griggs holds an MBA from the Wharton School at the University of Pennsylvania, a JD from University of Houston School of Law, and a BA from Vanderbilt University.
Calpine also declared succession plans for Jim Deidiker, Senior Vice President and Chief Accounting Officer (CAO), who is planning to retire. Jeff Koshkin, presently Vice President and Controller, will succeed Mr. Deidiker on August 1. Mr. Deidiker has agreed to remain at the company in a consultative capacity until March 15, 2016.
Calpine Corporation, a wholesale power generation company, owns and operates natural gas-fired and geothermal power plants in North America. It operates natural gas-fired combustion turbines and renewable geothermal conventional steam turbines.
Shares of Hecla Mining Co. (NYSE:HL), during its Wednesday’s current trading session gained 3.13%, and is now trading at $3.25.
Hecla Mining Company, declared first quarter net income applicable to common stockholders of $12.4 million, or $0.03 per basic share, and adjusted net loss applicable to common stockholders of $7.0 million, or $0.02 per basic share.
FIRST QUARTER 2015 HIGHLIGHTS AND NOTEWORTHY ITEMS
- Sales of $119.1 million.
- Operating cash flow of $21.4 million.
- Adjusted EBITDA of $35.0 million.
- Total silver production of 2.9 million ounces at a cash cost, after by-product credits, per silver ounce of $4.93.
- Total gold production of 40,650 ounces, of which 25,411 ounces were produced at Casa Berardi at a cash cost, after by-product credits, per gold ounce of $974.
- Silver equivalent production of 8.7 million ounces.
- Cash and cash equivalents of $196 million.
- Reached a contract to acquire Revett Mining Company for about $20 million of stock.
- Reviewing multiple third-party mill opportunities for San Sebastian project and have all major permits for mining.
- Affirmed 2015 guidance for production and cash cost, after by-product credits, in addition to capital and exploration spending.
Hecla Mining Company, together with its auxiliaries, discovers, acquires, develops, produces, and markets precious and base metal deposits worldwide. The company offers unrefined gold and silver bullion bars to precious metals traders; and lead, zinc, and bulk concentrates to custom smelters and brokers.
Finally, Opko Health, Inc. (NYSE:OPK), gained 5.74% Wednesday, hitting its highest level.
OPKO Health, declared the acquisition of EirGen Pharma, Ltd., a growing, profitable and cash flow positive specialty pharmaceutical company focused on the development and commercial supply of high potency, high barrier to entry, pharmaceutical products for sale in the U.S., Canada, Japan, Australia, most European countries, and more than 40 others around the world.
EirGen, based in Waterford, Ireland, was founded by two former executives of IVAX Pharmaceuticals, Tom Brennan and Patsy Carney. The company, situated in a state of the art high containment research and development, and manufacturing facility, is approved by the FDA, EMEA (European Health Authorities) and the PMDA (Japanese Health Authorities). High potency drugs such as those used for cancer chemotherapy are typically unsuitable for manufacture in normal multi-product facilities due to cross contamination risks.
To date, EirGen and its commercial partners have filed 10 product applications with the FDA and 5 each in Europe and Japan. EirGen has a strong research and development portfolio of over 20 niche, high barrier to entry drugs and, with access to additional capital that OPKO will provide, together with the benefits of Irish government programs to encourage research and development in Ireland, EirGen will rapidly expand its drug portfolio.
OPKO Health, Inc., a biopharmaceutical and diagnostics company, engages in the discovery, development, and commercialization of novel and proprietary technologies in the United States and internationally. It operates through two segments, Pharmaceuticals and Diagnostics.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
